Underestimated associated features in CMT neuropathies: Clinical indicators for the causative gene?

Brain and Behavior

Volumn 6, Issue 4, 2016, Pages 1-14

  Werheid, Friederike ^a   Azzedine, Hamid ^a   Zwerenz, Eva ^a   Bozkurt, Ahmet ^a,b   Moeller, Marcus J ^a   Lin, Lilian ^a   Mull, Michael ^a   Häusler, Martin ^a   Schulz, Jörg B ^a,c   Weis, Joachim ^a   Claeys, Kristl G ^a,d  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b AGAPLESION MARKUS KRANKENHAUS   (Germany)

^c JARA Translational Brain Medicine   (Germany)

^d UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

HMSN; RLS; Additional symptoms; Hereditary motor and sensory neuropathy; Pupillary abnormalities

Indexed keywords

MITOFUSIN 2;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ELECTRON MICROSCOPY; FEMALE; GENE; GENE MUTATION; GENETIC ASSOCIATION; GJB1 GENE; GLOMERULOSCLEROSIS; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; HUMAN TISSUE; HYPERTROPHY; LUMBAR PUNCTURE; MALE; META ANALYSIS; MICROSATELLITE MARKER; MIDDLE AGED; MOLECULAR GENETICS; MPZ GENE; MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION; NERVE CONDUCTION; NUCLEAR MAGNETIC RESONANCE IMAGING; PHENOTYPE; PRIORITY JOURNAL; RESPIRATORY FAILURE; RESTLESS LEGS SYNDROME; SYSTEMATIC REVIEW; CHILD; COHORT ANALYSIS; DIAGNOSTIC IMAGING; GENETICS; GENOTYPE; PATHOLOGY; PATHOPHYSIOLOGY; YOUNG ADULT;

ADULT; AGED; CHARCOT-MARIE-TOOTH DISEASE; CHILD; COHORT STUDIES; FEMALE; GENOTYPE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PHENOTYPE; YOUNG ADULT;

EID: 84959452102     PISSN: None     EISSN: 21623279     Source Type: Journal    
DOI: 10.1002/brb3.451     Document Type: Article

References (47)

1. Ananth, U., Athena Diagnostics Inc. 1999. Personal data. http://www.molgen.ua.ac.be/cmtmutations/Mutations/Mutations.cfm
2. Andermann, F., D. L. Lloyd-Smith, H. Mavor, and G. Mathieson . 1962. Observations on hypertrophic neuropathy of Dejerine and Sottas. Neurology 12:712-724.
3. Azzedine, H., J. Senderek, C. Rivolta, and R. Chrast . 2012. Molecular genetics of charcot-marie-tooth disease: from genes to genomes. Mol. Syndromol. 3:204-214.
4. Boentert, M., R. Dziewas, A. Heidbreder, S. Happe, I. Kleffner, S. Evers, et al. 2010. Fatigue, reduced sleep quality and restless legs syndrome in Charcot-Marie-Tooth disease: a web-based survey. J. Neurol. 257:646-652.
5. Boentert, M., K. Knop, C. Schuhmacher, B. Gess, A. Okegwo, and P. Young . 2014. Sleep disorders in Charcot-Marie-Tooth disease type 1. J. Neurol. Neurosurg. Psychiatry 85:319-325.
6. Bort, S., E. Nelis, V. Timmerman, T. Sevilla, A. Cruz-Martinez, F. Martinez, et al. 1997. Mutational analysis of the MPZ, PMP22 and Cx32 genes in patients of Spanish ancestry with Charcot-Marie-Tooth disease and hereditary neuropathy with liability to pressure palsies. Hum. Genet. 99:746-754.
7. Boyer, O., F. Nevo, E. Plaisier, B. Funalot, O. Gribouval, G. Benoit, et al. 2011. INF2 mutations in Charcot-Marie-Tooth disease with glomerulopathy. N. Engl. J. Med. 365:2377-2388.
8. Butefisch, C., L. Gutmann, and L. Gutmann . 1999. Compression of spinal cord and cauda equina in Charcot-Marie-Tooth disease type 1A. Neurology 52:890-891.
9. Cellerini, M., S. Salti, V. Desideri, and G. Marconi . 2000. MR imaging of the cauda equina in hereditary motor sensory neuropathies: correlations with sural nerve biopsy. AJNR Am. J. Neuroradiol. 21:1793-1798.
10. Chance, P. F., M. K. Alderson, K. A. Leppig, M. W. Lensch, N. Matsunami, B. Smith, et al. 1993. DNA deletion associated with hereditary neuropathy with liability to pressure palsies. Cell 72:143-151.
11. Chung, K. W., S. B. Kim, K. D. Park, K. G. Choi, J. H. Lee, H. W. Eun, et al. 2006. Early onset severe and late-onset mild Charcot-Marie-Tooth disease with mitofusin 2 (MFN2) mutations. Brain 129:2103-2118.
12. Davis, C. J., W. G. Bradley, and R. Madrid . 1978. The peroneal muscular atrophy syndrome: clinical, genetic, electrophysiological and nerve biopsy studies. I. Clinical, genetic and electrophysiological findings and classification. J. Genet. Hum. 26:311-349.
13. De Jonghe, P., V. Timmerman, C. Ceuterick, E. Nelis, E. De Vriendt, A. Lofgren, et al. 1999. The Thr124Met mutation in the peripheral myelin protein zero (MPZ) gene is associated with a clinically distinct Charcot-Marie-Tooth phenotype. Brain 122(Pt 2):281-290.
14. Eggers, S. D., S. C. Keswani, G. Melli, and D. R. Cornblath . 2004. Clinical and genetic description of a family with Charcot-Marie-Tooth disease type 1B from a transmembrane MPZ mutation. Muscle Nerve 29:867-869.
15. Fabrizi, G. M., M. Pellegrini, C. Angiari, T. Cavallaro, A. Morini, F. Taioli, et al. 2006. Gene dosage sensitivity of a novel mutation in the intracellular domain of P0 associated with Charcot-Marie-Tooth disease type 1B. Neuromuscul. Disord. 16:183-187.
16. Gabreels-Festen, A. A., J. E. Hoogendijk, P. H. Meijerink, F. J. Gabreels, P. A. Bolhuis, S. van Beersum, et al. 1996. Two divergent types of nerve pathology in patients with different P0 mutations in Charcot-Marie-Tooth disease. Neurology 47:761-765.
17. Gerding, W. M., J. Koetting, J. T. Epplen, and C. Neusch . 2009. Hereditary motor and sensory neuropathy caused by a novel mutation in LITAF. Neuromuscul. Disord. 19:701-703.
18. Ginsberg, L., A. D. Platts, and P. K. Thomas . 1995. Chronic inflammatory demyelinating polyneuropathy mimicking a lumbar spinal stenosis syndrome. J. Neurol. Neurosurg. Psychiatry 59:189-191.
19. Harding, A. E., and P. K. Thomas . 1980. The clinical features of hereditary motor and sensory neuropathy types I and II. Brain 103:259-280.
20. Hattan, E., C. Chalk, and R. B. Postuma . 2009. Is there a higher risk of restless legs syndrome in peripheral neuropathy? Neurology 72:955-960.
21. Hattori, N., M. Yamamoto, T. Yoshihara, H. Koike, M. Nakagawa, H. Yoshikawa, et al. 2003. Demyelinating and axonal features of Charcot-Marie-Tooth disease with mutations of myelin-related proteins (PMP22, MPZ and Cx32): a clinicopathological study of 205 Japanese patients. Brain 126:134-151.
22. Iannaccone, S., M. Zucconi, P. Marchettini, L. Ferini-Strambi, R. Nemni, A. Quattrini, et al. 1995. Evidence of peripheral axonal neuropathy in primary restless legs syndrome. Mov. Disord. 10:2-9.
23. Kleopa, K. A., L. N. Sutton, J. Ong, G. Tennekoon, and A. E. Telfeian . 2002. Conus medulla-cauda compression from nerve root hypertrophy in a child with Dejerine-Sottas syndrome: improvement with laminectomy and duraplasty. Case report. J. Neurosurg. 97:244-247.
24. Lupski, J. R., R. M. de Oca-Luna, S. Slaugenhaupt, L. Pentao, V. Guzzetta, B. J. Trask, et al. 1991. DNA duplication associated with Charcot-Marie-Tooth disease type 1A. Cell 66:219-232.
25. Mademan, I., T. Deconinck, A. Dinopoulos, T. Voit, U. Schara, K. Devriendt, et al. 2013. De novo INF2 mutations expand the genetic spectrum of hereditary neuropathy with glomerulopathy. Neurology 81:1953-1958.
26. Marchini, C., S. Z. Marsala, M. Bendini, F. Taioli, G. Damante, I. R. Lonigro, et al. 2009. Myelin protein zero Val102 fs mutation manifesting with isolated spinal root hypertrophy. Neuromuscul. Disord. 19:849-852.
27. Mersiyanova, I. V., A. V. Perepelov, A. V. Polyakov, V. F. Sitnikov, E. L. Dadali, R. B. Oparin, et al. 2000. A new variant of Charcot-Marie-Tooth disease type 2 is probably the result of a mutation in the neurofilament-light gene. Am. J. Hum. Genet. 67:37-46.
28. Murphy, S. M., D. N. Herrmann, M. P. McDermott, S. S. Scherer, M. E. Shy, M. M. Reilly, et al. 2011. Reliability of the CMT neuropathy score (second version) in Charcot-Marie-Tooth disease. J. Peripher. Nerv. Syst. 16:191-198.
29. Numakura, C., C. Lin, T. Ikegami, P. Guldberg, and K. Hayasaka . 2002. Molecular analysis in Japanese patients with Charcot-Marie-Tooth disease: DGGE analysis for PMP22, MPZ, and Cx32/GJB1 mutations. Hum. Mutat. 20:392-398.
30. van Paassen, B. W., A. J. van der Kooi, K. Y. van Spaendonck-Zwarts, C. Verhamme, F. Baas, and M. de Visser . 2014. PMP22 related neuropathies: Charcot-Marie-Tooth disease type 1A and hereditary neuropathy with liability to pressure palsies. Orphanet J. Rare Dis. 9:38.
31. Raeymaekers, P., V. Timmerman, E. Nelis, P. De Jonghe, J. E. Hoogendijk, F. Baas, et al. 1991. Duplication in chromosome 17p11.2 in Charcot-Marie-Tooth neuropathy type 1a (CMT 1a). The HMSN Collaborative Research Group. Neuromuscul. Disord. 1:93-97.
32. Roos, A., J. Weis, R. Korinthenberg, H. Fehrenbach, M. Hausler, S. Zuchner, et al. 2015. Inverted formin 2-related Charcot-Marie-Tooth disease: extension of the mutational spectrum and pathological findings in Schwann cells and axons. J. Peripher. Nerv. Syst. 20:52-59.
33. Rossor, A. M., J. M. Polke, H. Houlden, and M. M. Reilly . 2013. Clinical implications of genetic advances in Charcot-Marie-Tooth disease. Nat. Rev. Neurol. 9:562-571.
34. Rothdach, A. J., C. Trenkwalder, J. Haberstock, U. Keil, and K. Berger . 2000. Prevalence and risk factors of RLS in an elderly population: the MEMO study. Memory and morbidity in Augsburg elderly. Neurology 54:1064-1068.
35. Schröder, J. M. 2001. Pathology of peripheral nerves. An atlas of structural and molecular pathological changes.
36. Simonati, A., G. M. Fabrizi, F. Taioli, A. Polo, R. Cerini, and N. Rizzuto . 2002. Dejerine-Sottas neuropathy with multiple nerve roots enlargement and hypomyelination associated with a missense mutation of the transmembrane domain of MPZ/P0. J. Neurol. 249:1298-1302.
37. Skre, H. 1974. Genetic and clinical aspects of Charcot-Marie-Tooth's disease. Clin. Genet. 6:98-118.
38. Stojkovic, T., J. de Seze, O. Dubourg, M. C. Arne-Bes, S. Tardieu, J. C. Hache, et al. 2003. Autonomic and respiratory dysfunction in Charcot-Marie-Tooth disease due to Thr124Met mutation in the myelin protein zero gene. Clin. Neurophysiol. 114:1609-1614.
39. Street, V. A., G. Meekins, H. P. Lipe, W. K. Seltzer, G. T. Carter, G. H. Kraft, et al. 2002. Charcot-Marie-Tooth neuropathy: clinical phenotypes of four novel mutations in the MPZ and Cx 32 genes. Neuromuscul. Disord. 12:643-650.
40. Sugimoto, T., K. Ochi, N. Hosomi, T. Takahashi, H. Ueno, T. Nakamura, et al. 2013. Ultrasonographic nerve enlargement of the median and ulnar nerves and the cervical nerve roots in patients with demyelinating Charcot-Marie-Tooth disease: distinction from patients with chronic inflammatory demyelinating polyneuropathy. J. Neurol. 260:2580-2587.
41. Symonds, C. P., and W. Blackwood . 1962. Spinal cord compression in hypertrophic neuritis. Brain 85:251-260.
42. Timmerman, V., V. E. Clowes, and E. Reid . 2013. Overlapping molecular pathological themes link Charcot-Marie-Tooth neuropathies and hereditary spastic paraplegias. Exp. Neurol. 246:14-25.
43. Timmerman, V., A. V. Strickland, and S. Zuchner . 2014. Genetics of Charcot-Marie-Tooth (CMT) disease within the frame of the human genome project success. Genes 5:13-32.
44. Verhoeven, K., K. G. Claeys, S. Zuchner, J. M. Schroder, J. Weis, C. Ceuterick, et al. 2006. MFN2 mutation distribution and genotype/phenotype correlation in Charcot-Marie-Tooth type 2. Brain 129:2093-2102.
45. Watanabe, M., N. Yamamoto, N. Ohkoshi, H. Nagata, Y. Kohno, A. Hayashi, et al. 2002. Corticosteroid- responsive asymmetric neuropathy with a myelin protein zero gene mutation. Neurology 59:767-769.
46. Weis, J., S. Brandner, M. Lammens, C. Sommer, and J. M. Vallat . 2012. Processing of nerve biopsies: a practical guide for neuropathologists. Clin. Neuropathol. 31:7-23.
47. Zuchner, S., I. V. Mersiyanova, M. Muglia, N. Bissar-Tadmouri, J. Rochelle, E. L. Dadali, et al. 2004. Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A. Nat. Genet. 36:449-451.